TEOSYAL® ULTIMATE

Product Overview: TEOSYAL® ULTIMATE

TEOSYAL® ULTIMATE is a sterile, non-pyrogenic, transparent, highly cross-linked hyaluronic acid (HA) gel of non-animal origin. Manufactured by Teoxane Laboratories (Geneva, Switzerland), this high-viscosity formulation is specifically engineered for substantial volume creation and facial sculpting. It is designed for deep injection into the subdermal or pre-periosteal layers to provide significant structural support and augmentation.

This product is indicated for restoring large volumes and remodeling facial contours, particularly in areas requiring significant projection like the cheeks, chin, and jawline.

Note: TEOSYAL® ULTIMATE is a medical device intended for use only by licensed medical professionals with thorough knowledge of facial anatomy and expertise in deep-plane injection techniques for volumizing fillers.

Mechanism of Action and Properties

TEOSYAL® ULTIMATE provides significant volumizing effects primarily due to its high concentration and degree of cross-linking of hyaluronic acid. This dense, cohesive gel structure offers strong tissue support and lift upon injection into deep tissue planes. Unlike fillers primarily designed for dynamic integration, TEOSYAL® ULTIMATE prioritizes projection and stability for effective facial sculpting. The hyaluronic acid component also contributes to tissue hydration by binding water molecules.

The extensive cross-linking contributes to the product’s resistance to degradation, potentially offering extended duration of effect compared to less cross-linked HA fillers. Longevity typically ranges up to 18 months, though individual patient results can vary significantly based on factors like metabolism, injection site, volume used, and lifestyle.

This formulation does not contain integrated lidocaine; appropriate patient comfort measures should be considered by the practitioner.

Indications and Usage

TEOSYAL® ULTIMATE is indicated for addressing significant volume loss and enhancing facial architecture, including:

• Malar (cheekbone) augmentation
• Zygomatic arch definition
• Chin projection and reshaping
• Jawline contouring and definition
• Correction of severe facial lipoatrophy
• Temple volumization

Administration requires deep injection techniques (subdermal or supra-periosteal) by qualified practitioners using appropriate needles or cannulas, adhering strictly to aseptic procedures.

Expected Outcomes

Professional application aims to achieve:

• Significant augmentation of facial volume in targeted areas
• Enhanced facial projection and definition (e.g., cheeks, chin)
• Improved overall facial contours and structure
• Correction of deep volume deficits and concavities
• Long-lasting results for facial remodeling

Potential Adverse Events

Due to the deep injection placement and high volume nature, practitioners must carefully discuss potential side effects. Possible adverse events include:

• Common Reactions (Typically Transient): Post-injection swelling, bruising, erythema (redness), pain, tenderness, palpable firmness or lumpiness at the injection site. These usually resolve within one to two weeks.
• Less Common/Rare but Serious Reactions: Prolonged swelling or firmness, significant hematoma, infection, inflammation, hypersensitivity/allergic reaction, nodule or granuloma formation (potentially delayed onset), skin discoloration, abscess formation, contour irregularities, vascular complications (compression or intravascular injection, rare but serious, requiring immediate intervention), nerve impingement/effects (rare), tissue necrosis (rare).

Thorough understanding of deep facial anatomy, safe injection planes, and management of potential complications is essential. Patients must report any severe, persistent, or concerning reactions promptly.

Storage Conditions

Store between 2°C and 25°C. Avoid freezing and direct sunlight exposure. Ensure packaging integrity before use.

Disclaimer: This summary is for informational purposes only. Healthcare professionals must consult the full instructions provided with TEOSYAL® ULTIMATE before administration for complete details on product characteristics, indications, contraindications, warnings, precautions, injection procedures, and potential adverse events.